List of Tables
Table 1. Prilide Antihypertensive Drugs Market Trends
Table 2. Prilide Antihypertensive Drugs Market Drivers & Opportunity
Table 3. Prilide Antihypertensive Drugs Market Challenges
Table 4. Prilide Antihypertensive Drugs Market Restraints
Table 5. Global Prilide Antihypertensive Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Prilide Antihypertensive Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Prilide Antihypertensive Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Prilide Antihypertensive Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Prilide Antihypertensive Drugs Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Prilide Antihypertensive Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Prilide Antihypertensive Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Prilide Antihypertensive Drugs
Table 13. Global Prilide Antihypertensive Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prilide Antihypertensive Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Prilide Antihypertensive Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Prilide Antihypertensive Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Prilide Antihypertensive Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Prilide Antihypertensive Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Prilide Antihypertensive Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Prilide Antihypertensive Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Prilide Antihypertensive Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Prilide Antihypertensive Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Prilide Antihypertensive Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Prilide Antihypertensive Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Prilide Antihypertensive Drugs Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Prilide Antihypertensive Drugs Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Prilide Antihypertensive Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Prilide Antihypertensive Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Prilide Antihypertensive Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Prilide Antihypertensive Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Prilide Antihypertensive Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Prilide Antihypertensive Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Prilide Antihypertensive Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Prilide Antihypertensive Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Prilide Antihypertensive Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Prilide Antihypertensive Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Prilide Antihypertensive Drugs Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Prilide Antihypertensive Drugs Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Prilide Antihypertensive Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Prilide Antihypertensive Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Prilide Antihypertensive Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Prilide Antihypertensive Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Prilide Antihypertensive Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Prilide Antihypertensive Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Prilide Antihypertensive Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Prilide Antihypertensive Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Prilide Antihypertensive Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Prilide Antihypertensive Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Prilide Antihypertensive Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Prilide Antihypertensive Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Prilide Antihypertensive Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Prilide Antihypertensive Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Prilide Antihypertensive Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Prilide Antihypertensive Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Prilide Antihypertensive Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Merck Company Information
Table 58. Merck Introduction and Business Overview
Table 59. Merck Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Merck Prilide Antihypertensive Drugs Product Offerings
Table 61. Merck Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Introduction and Business Overview
Table 64. Pfizer Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Pfizer Prilide Antihypertensive Drugs Product Offerings
Table 66. Pfizer Recent Development
Table 67. Sanofi Company Information
Table 68. Sanofi Introduction and Business Overview
Table 69. Sanofi Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Sanofi Prilide Antihypertensive Drugs Product Offerings
Table 71. Sanofi Recent Development
Table 72. Abbott Company Information
Table 73. Abbott Introduction and Business Overview
Table 74. Abbott Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Abbott Prilide Antihypertensive Drugs Product Offerings
Table 76. Abbott Recent Development
Table 77. Novartis Company Information
Table 78. Novartis Introduction and Business Overview
Table 79. Novartis Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Novartis Prilide Antihypertensive Drugs Product Offerings
Table 81. Novartis Recent Development
Table 82. Changzhou Pharmaceutical Company Information
Table 83. Changzhou Pharmaceutical Introduction and Business Overview
Table 84. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 86. Changzhou Pharmaceutical Recent Development
Table 87. Humanwell Pharmaceutical Company Information
Table 88. Humanwell Pharmaceutical Introduction and Business Overview
Table 89. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 91. Humanwell Pharmaceutical Recent Development
Table 92. Hengcheng Pharmaceutical Company Information
Table 93. Hengcheng Pharmaceutical Introduction and Business Overview
Table 94. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 96. Hengcheng Pharmaceutical Recent Development
Table 97. Hengwei Pharmaceutical Company Information
Table 98. Hengwei Pharmaceutical Introduction and Business Overview
Table 99. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 101. Hengwei Pharmaceutical Recent Development
Table 102. Zhongfu Pharmaceutical Company Information
Table 103. Zhongfu Pharmaceutical Introduction and Business Overview
Table 104. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 106. Zhongfu Pharmaceutical Recent Development
Table 107. Likang Pharmaceutical Company Information
Table 108. Likang Pharmaceutical Introduction and Business Overview
Table 109. Likang Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Likang Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 111. Likang Pharmaceutical Recent Development
Table 112. Changjiang Pharmaceutical Company Information
Table 113. Changjiang Pharmaceutical Introduction and Business Overview
Table 114. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 116. Changjiang Pharmaceutical Recent Development
Table 117. Baiyunshan Pharmaceutical Company Information
Table 118. Baiyunshan Pharmaceutical Introduction and Business Overview
Table 119. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 121. Baiyunshan Pharmaceutical Recent Development
Table 122. Poly Pharm Company Information
Table 123. Poly Pharm Introduction and Business Overview
Table 124. Poly Pharm Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Poly Pharm Prilide Antihypertensive Drugs Product Offerings
Table 126. Poly Pharm Recent Development
Table 127. Lukang Group Company Information
Table 128. Lukang Group Introduction and Business Overview
Table 129. Lukang Group Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Lukang Group Prilide Antihypertensive Drugs Product Offerings
Table 131. Lukang Group Recent Development
Table 132. Baili Pharmaceutical Company Information
Table 133. Baili Pharmaceutical Introduction and Business Overview
Table 134. Baili Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Baili Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 136. Baili Pharmaceutical Recent Development
Table 137. Huahai Pharmaceutical Company Information
Table 138. Huahai Pharmaceutical Introduction and Business Overview
Table 139. Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Huahai Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 141. Huahai Pharmaceutical Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Prilide Antihypertensive Drugs Downstream Customers
Table 145. Prilide Antihypertensive Drugs Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Prilide Antihypertensive Drugs Product Picture
Figure 2. Global Prilide Antihypertensive Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Prilide Antihypertensive Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Prilide Antihypertensive Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Prilide Antihypertensive Drugs Sales Price (2019-2030) & (US$/Unit)
Figure 6. Prilide Antihypertensive Drugs Report Years Considered
Figure 7. Global Prilide Antihypertensive Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Prilide Antihypertensive Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Prilide Antihypertensive Drugs Revenue in 2023
Figure 10. Prilide Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Captopril Picture
Figure 12. Enalapril Picture
Figure 13. Lisinopril Picture
Figure 14. Fosinopril Picture
Figure 15. Others Picture
Figure 16. Global Prilide Antihypertensive Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Prilide Antihypertensive Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Prilide Antihypertensive Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 19. Global Prilide Antihypertensive Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Prilide Antihypertensive Drugs Price by Type (2019-2030) & (US$/Unit)
Figure 21. Product Picture of Hospital
Figure 22. Product Picture of Clinic
Figure 23. Global Prilide Antihypertensive Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Prilide Antihypertensive Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Prilide Antihypertensive Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Prilide Antihypertensive Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Prilide Antihypertensive Drugs Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America Prilide Antihypertensive Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Prilide Antihypertensive Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Prilide Antihypertensive Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Prilide Antihypertensive Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Prilide Antihypertensive Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Prilide Antihypertensive Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Prilide Antihypertensive Drugs Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Prilide Antihypertensive Drugs Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Prilide Antihypertensive Drugs Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Prilide Antihypertensive Drugs Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Prilide Antihypertensive Drugs Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Prilide Antihypertensive Drugs Sales Volume (%), (2019-2030)
Figure 40. United States Prilide Antihypertensive Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Prilide Antihypertensive Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Prilide Antihypertensive Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Prilide Antihypertensive Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Prilide Antihypertensive Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Prilide Antihypertensive Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. China Prilide Antihypertensive Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Prilide Antihypertensive Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. China Prilide Antihypertensive Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Prilide Antihypertensive Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Prilide Antihypertensive Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Prilide Antihypertensive Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Prilide Antihypertensive Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Prilide Antihypertensive Drugs Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Prilide Antihypertensive Drugs Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Prilide Antihypertensive Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Prilide Antihypertensive Drugs Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Prilide Antihypertensive Drugs Sales Value by Application (%), 2023 VS 2030
Figure 58. India Prilide Antihypertensive Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Prilide Antihypertensive Drugs Sales Value by Type (%), 2023 VS 2030
Figure 60. India Prilide Antihypertensive Drugs Sales Value by Application (%), 2023 VS 2030
Figure 61. Prilide Antihypertensive Drugs Industrial Chain
Figure 62. Prilide Antihypertensive Drugs Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
